Summit Therapeutics
Clinical trials sponsored by Summit Therapeutics, explained in plain language.
-
New lung cancer drug faces off against standard in major trial
Disease control Recruiting nowThis study compares a new drug, ivonescimab, to the current standard treatment, pembrolizumab, for people with advanced lung cancer that has spread. It is for patients whose tumors have high levels of a protein called PD-L1. The goal is to see which drug helps people live longer …
Phase: PHASE3 • Sponsor: Summit Therapeutics • Aim: Disease control
Last updated May 26, 2026 03:57 UTC
-
New hope for lung cancer: ivonescimab takes on keytruda in massive global trial
Disease control Recruiting nowThis study compares two drug combinations for people with advanced non-small cell lung cancer that has spread. One group gets ivonescimab plus chemotherapy, the other gets pembrolizumab (Keytruda) plus chemotherapy. The goal is to see which combination helps people live longer an…
Phase: PHASE3 • Sponsor: Summit Therapeutics • Aim: Disease control
Last updated May 26, 2026 03:55 UTC
-
New hope for advanced colon cancer: experimental drug combo enters final testing phase
Disease control Recruiting nowThis phase 3 study tests whether a new drug called ivonescimab, when added to standard chemotherapy, works better than the current standard treatment (bevacizumab plus chemo) for people with metastatic colorectal cancer that has spread. About 600 adults who have not had prior tre…
Phase: PHASE3 • Sponsor: Summit Therapeutics • Aim: Disease control
Last updated May 26, 2026 03:53 UTC